SABAPATHY, Suthakar; NESLUSAN, Cheryl; YOONG, Kim; TESCHEMAKER, Anna; JOHANSEN, Pierre; WILLIS, Michael. COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 23, n. 2, 2018. Disponível em: https://mail.jptcp.com/index.php/jptcp/article/view/206. Acesso em: 19 nov. 2024.